HomeNewsCricketYusuf Pathan suspended for failing dope test

Yusuf Pathan suspended for failing dope test

The BCCI said it is "satisfied" with Pathan's explanation that was using the medication to "treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug"

January 09, 2018 / 15:58 IST
India's batsman Yusuf Pathan (L) and Shanthakumaran Sreesanth look on after losing the ODI series to South Africa at Super sport park stadium in Centurion, January 23, 2011. REUTERS/Siphiwe Sibeko (SOUTH AFRICA - Tags: SPORT CRICKET) - GM1E71O02FF01

Indian all-rounder Yusuf Pathan was today handed a five-month retrospective suspension for failing a dope test, a sanction which will end on January 14, after the BCCI accepted that the violation was inadvertent.

"Mr Yusuf Pathan has been suspended for a doping violation. Mr Pathan had inadvertently ingested a prohibited substance, which can be commonly found in cough syrups," the BCCI said in a statement.

The 35-year-old Pathan had provided a urine sample as part of the BCCI's anti-doping testing program during a domestic T20 competition on March 16 last year.

"His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In and Out of Competition in the WADA Prohibited List of Substances," the BCCI stated.

The all-rounder, who has played 57 ODIs and 22 T20 Internationals for India, was charged with the "commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti- Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge".

"Mr Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance," the BCCI explained.

The BCCI said it is "satisfied" with Pathan's explanation that was using the medication to "treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug".

"Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr Pathan's explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of five months should apply, together with the disqualification of certain results," the BCCI stated.

The BCCI said Pathan had been provisionally suspended on October 28 last year and the Board has now decided to back- date the period of his final suspension from August 15.

"...there is discretion under BCCI ADR Article 10.10.2 to back-date the start date of the period of ineligibility still further on account of Mr Pathan's prompt admission of his ADRV upon being confronted with it by the BCCI, and under BCCI ADR Article 10.10.1 on account of the delays in the results management in this case that are not attributable to Mr Pathan.

"In all of the circumstances, the five-month period of ineligibility will be deemed to have started to run on 15 August 2017 and end at midnight on 14 January 2018," the Board stated.

The development comes amid the BCCI's stoic opposition to allow the National Anti-Doping Agency to test cricketers. The Board has refused to sign up with NADA despite repeated requests by the agency.

After this, the ace cricketer thanked the Indian cricket board for allowing him to plead his case in a fair and reasonable manner. In a statement, Pathan clarified that the prohibited substance found in his sample was because of a medicine he was taking for a throat infection. He further thanked everyone who supported him and added to be more careful  with his consumption henceforth.

PTI
first published: Jan 9, 2018 01:59 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
CloseOutskill Genai